The window of opportunities for targeted therapy in BRAFwt/NRASwt/KITwt melanoma: biology and clinical implications of fusion proteins and other mutationsB.M. Berger, Erika Richtig, Georg Richtig et al.|Italian Journal of Dermatology and Venereology|2018Cited by 7
Circulating Tumor DNA as a Marker for Treatment Response in Metastatic Melanoma Patients Using Next-Generation Sequencing—A Prospective Feasibility StudyB.M. Berger, Ariane Aigelsreiter, Andrea Thueringer et al.|Cancers|2021Cited by 4